Prelude Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,973
| Closed | -$95.7K | – | 1335 |
|
|
2023
Q1 | $95.7K | Buy |
+10,973
| New | +$95.7K | 0.01% | 858 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1966 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1786 |
|
|
2019
Q3 | – | Sell |
-767
| Closed | -$5K | – | 1688 |
|
|
2019
Q2 | $5K | Buy |
+767
| New | +$5K | ﹤0.01% | 1130 |
|
|
2019
Q1 | – | Sell |
-905
| Closed | -$7K | – | 1841 |
|
|
2018
Q4 | $7K | Buy |
905
+95
| +12% | +$735 | ﹤0.01% | 1133 |
|
|
2018
Q3 | $9K | Buy |
+810
| New | +$9K | ﹤0.01% | 1133 |
|
|
2018
Q2 | – | Sell |
-906
| Closed | -$12K | – | 1732 |
|
|
2018
Q1 | $12K | Buy |
906
+416
| +85% | +$5.51K | ﹤0.01% | 1190 |
|
|
2017
Q4 | $5K | Sell |
490
-6,610
| -93% | -$67.4K | ﹤0.01% | 1131 |
|
|
2017
Q3 | $57K | Buy |
+7,100
| New | +$57K | 0.01% | 966 |
|